{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:47:35Z","timestamp":1788504455364,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ejca.2024.114104","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T12:26:38Z","timestamp":1715084798000},"page":"114104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Trends in incidence, treatment, and relative survival of colorectal cancer in the Netherlands between 2000 and 2021"],"prefix":"10.1016","volume":"205","author":[{"given":"Hidde","family":"Swartjes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke P.C.","family":"Sijtsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes A.G.","family":"Elferink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice N.","family":"van Erning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon M.G.","family":"Moons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk M.W.","family":"Verheul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Berb\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline A.J.","family":"Vissers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes H.W.","family":"de Wilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejca.2024.114104_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.ejca.2024.114104_bib2","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1136\/gutjnl-2018-317592","article-title":"Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years","volume":"68","author":"Vuik","year":"2019","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.ejca.2024.114104_bib3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S2468-1253(19)30147-5","article-title":"Changes in colorectal cancer incidence in seven high-income countries: a population-based study","volume":"4","author":"Araghi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ejca.2024.114104_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejca.2022.01.029","article-title":"Incidence, treatment and relative survival of early-onset colorectal cancer in the Netherlands since 1989","volume":"166","author":"Swartjes","year":"2022","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.ejca.2024.114104_bib5","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1470-2045(21)00199-6","article-title":"Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study","volume":"22","author":"Cardoso","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2024.114104_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S2468-1253(21)00368-X","article-title":"Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study","volume":"7","author":"Breekveldt","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.ejca.2024.114104_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw322","article-title":"Colorectal cancer incidence patterns in the United States, 1974-2013","volume":"109","author":"Siegel","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2024.114104_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejca.2022.05.032","article-title":"Survival trends in patients diagnosed with colon and rectal cancer in the nordic countries 1990-2016: the NORDCAN survival studies","volume":"172","author":"Lundberg","year":"2022","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.ejca.2024.114104_bib9","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1002\/ijc.31785","article-title":"An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients","volume":"143","author":"Brouwer","year":"2018","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2024.114104_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jamaoncol.2022.6116","article-title":"Trends in the characteristics, treatment, and outcomes of rectal adenocarcinoma in the US From 2004 to 2019: a national cancer database analysis","volume":"9","author":"Emile","year":"2023","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2024.114104_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2024.114104_bib12","unstructured":"Netherlands Cancer Registry. 2023. https:\/\/iknl.nl\/en\/ncr."},{"key":"10.1016\/j.ejca.2024.114104_bib13","unstructured":"International Classification of Diseases for Oncology; 2013."},{"key":"10.1016\/j.ejca.2024.114104_bib14","unstructured":"The TNM Classification of Malignant Tumours; 2016."},{"issue":"1","key":"10.1016\/j.ejca.2024.114104_bib15","first-page":"104","article-title":"International rules for multiple primary cancers","volume":"6","author":"International Association of Cancer R","year":"2005","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"10.1016\/j.ejca.2024.114104_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","article-title":"On estimation in relative survival","volume":"68","author":"Pohar Perme","year":"2012","journal-title":"Biometrics"},{"issue":"9","key":"10.1016\/j.ejca.2024.114104_bib17","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ejca.2013.09.019","article-title":"Choosing the net survival method for cancer survival estimation","volume":"51","author":"Seppa","year":"2015","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2024.114104_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2024.114104_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2022.10.016","article-title":"Advanced-stage CRC incidence patterns following the phased implementation of the CRC screening programme in the Netherlands","volume":"178","author":"Breekveldt","year":"2023","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2024.114104_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejso.2014.11.003","article-title":"Improved quality of care for patients undergoing an abdominoperineal excision for rectal cancer","volume":"41","author":"Bokkerink","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2024.114104_bib21","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.ejso.2018.04.008","article-title":"Clinical lymph node staging in colorectal cancer; a flip of the coin?","volume":"44","author":"Brouwer","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2024.114104_bib22","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ejso.2021.11.132","article-title":"Changes in rectal cancer treatment after the introduction of a national screening program; Increasing use of less invasive strategies within a national cohort","volume":"48","author":"Giesen","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2024.114104_bib23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/a-1637-9051","article-title":"Endoscopic full-thickness resection of T1 colorectal cancers: a retrospective analysis from a multicenter Dutch eFTR registry","volume":"54","author":"Zwager","year":"2022","journal-title":"Endoscopy"},{"issue":"5","key":"10.1016\/j.ejca.2024.114104_bib24","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/SLA.0000000000005417","article-title":"Colonoscopic-assisted laparoscopic wedge resection for colonic lesions: a prospective multicenter cohort study (LIMERIC-Study)","volume":"275","author":"Leicher","year":"2022","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ejca.2024.114104_bib25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.sla.0000257358.56863.ce","article-title":"The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma","volume":"246","author":"Peeters","year":"2007","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejca.2024.114104_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamasurg.2018.3752","article-title":"Long-term oncological and functional outcomes of chemoradiotherapy followed by organ-sparing transanal endoscopic microsurgery for distal rectal cancer: the CARTS study","volume":"154","author":"Stijns","year":"2019","journal-title":"JAMA Surg"},{"issue":"2","key":"10.1016\/j.ejca.2024.114104_bib27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S2468-1253(20)30333-2","article-title":"Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study","volume":"6","author":"Bach","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ejca.2024.114104_bib28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2468-1253(22)00392-2","article-title":"Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial","volume":"8","author":"Gerard","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.ejca.2024.114104_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019474","article-title":"Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study","volume":"7","author":"Rombouts","year":"2017","journal-title":"BMJ Open"},{"issue":"17","key":"10.1016\/j.ejca.2024.114104_bib30","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ejca.2024.114104_bib31","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"issue":"15_suppl","key":"10.1016\/j.ejca.2024.114104_bib32","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.3504","article-title":"Investigators obotIFT. FOxTROT: an international randomised controlled trial in 1052 patients (pts) evaluating neoadjuvant chemotherapy (NAC) for colon cancer","volume":"37","author":"Seymour","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2024.114104_bib33","unstructured":"Richtlijn Colorectaal Carcinoom (CRC): Federatie Medisch Specialisten, 2022."},{"issue":"10","key":"10.1016\/j.ejca.2024.114104_bib34","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","article-title":"Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Argil\u00e9s","year":"2020","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2024.114104_bib35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/DCR.0000000000002323","article-title":"The American society of colon and rectal surgeons clinical practice guidelines for the management of colon cancer","volume":"65","author":"Vogel","year":"2022","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"10.1016\/j.ejca.2024.114104_bib36","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJM199002083220602","article-title":"Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma","volume":"322","author":"Moertel","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2024.114104_bib37","doi-asserted-by":"crossref","unstructured":"Keikes L., Koopman M., Lemmens V., MGH VANO, Punt CJA. Practice Variation in the Adjuvant Treatment of Colon Cancer in the Netherlands: A Population-based Study. Anticancer Res; 2020, 40(8): 4331\u201341.","DOI":"10.21873\/anticanres.14436"},{"issue":"11","key":"10.1016\/j.ejca.2024.114104_bib38","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1093\/annonc\/mds102","article-title":"Increased adjuvant treatment and improved survival in elderly stage III colon cancer patients in The Netherlands","volume":"23","author":"van Steenbergen","year":"2012","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2024.114104_bib39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41591-022-02115-4","article-title":"Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer","volume":"29","author":"Kotani","year":"2023","journal-title":"Nat Med"},{"issue":"24","key":"10.1016\/j.ejca.2024.114104_bib40","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1056\/NEJMoa2200075","article-title":"Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer","volume":"386","author":"Tie","year":"2022","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ejca.2024.114104_bib41","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/DCR.0000000000001762","article-title":"The American society of colon and rectal surgeons clinical practice guidelines for the management of rectal cancer","volume":"63","author":"You","year":"2020","journal-title":"Dis Colon Rectum"},{"issue":"Suppl 4)","key":"10.1016\/j.ejca.2024.114104_bib42","doi-asserted-by":"crossref","first-page":"iv263","DOI":"10.1093\/annonc\/mdy161","article-title":"Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Glynne-Jones","year":"2018","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2024.114104_bib43","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/annonc\/mdu560","article-title":"Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial","volume":"26","author":"Breugom","year":"2015","journal-title":"Ann Oncol"},{"issue":"16_suppl","key":"10.1016\/j.ejca.2024.114104_bib44","article-title":"Upfront palliative resection of primary tumor versus no resection in patients with synchronous metastatic colorectal cancer: the randomized phase 3 CAIRO4 study of the Dutch Colorectal Cancer Group (DCCG)","volume":"41","author":"Kruijssen","year":"2023","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2024.114104_bib45","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10585-015-9719-0","article-title":"Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases","volume":"32","author":"van der Geest","year":"2015","journal-title":"Clin Exp Metastas"},{"issue":"1","key":"10.1016\/j.ejca.2024.114104_bib46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gutjnl-2020-320625","article-title":"Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project)","volume":"70","author":"Araghi","year":"2021","journal-title":"Gut"}],"updated-by":[{"DOI":"10.1016\/j.ejca.2024.114155","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000}}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924007603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924007603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T21:24:28Z","timestamp":1726089868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804924007603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":46,"alternative-id":["S0959804924007603"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2024.114104","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in incidence, treatment, and relative survival of colorectal cancer in the Netherlands between 2000 and 2021","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2024.114104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"114104"}}